title: Stage III carcinoma of the endometrium. Results of treatment.
abstract: The impact of treatment on survival was analysed in 45 patients with stage III carcinoma of the endometrium. Our results indicate that patients treated with a combination of surgery and radiation therapy did significantly better than those treated with radiation alone. The five-years survival was 57.3% and 17.5%, respectively (p = 0.01). Patients with clinical stage III (CS III) whose tumor could not be resected surgically did poorly than patients with pathological stage III (PS III). This difference, however, was not statistically significant (p = greater than 0.05). Treatment related complications were minimal. Overall survival of patients of 33.8% was directly attributable to increased pelvic and/or extra pelvic recurrences.
authors.affiliation: Radiation Oncology, Wayne State University.
authors.forename: K
authors.initials: K
authors.lastname: Ahmad
authors.forename: Y H
authors.initials: YH
authors.lastname: Kim
authors.forename: G
authors.initials: G
authors.lastname: Deppe
authors.forename: J
authors.initials: J
authors.lastname: Malone
authors.forename: T
authors.initials: T
authors.lastname: Hegarty
authors.forename: V
authors.initials: V
authors.lastname: Malviya
authors.forename: A
authors.initials: A
authors.lastname: Herskovic
authors.forename: V
authors.initials: V
authors.lastname: Ratanatharathorn
authors.forename: W A
authors.initials: WA
authors.lastname: Sakr
authors.forename: A
authors.initials: A
authors.lastname: Medina
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002277:Carcinoma / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D011878:Radiotherapy; D012189:Retrospective Studies; D016019:Survival Analysis; D014594:Uterine Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*